HUT47848A - Process for producing pharmaceuticals promoting vulnerary inflammation - Google Patents

Process for producing pharmaceuticals promoting vulnerary inflammation

Info

Publication number
HUT47848A
HUT47848A HU873554A HU355487A HUT47848A HU T47848 A HUT47848 A HU T47848A HU 873554 A HU873554 A HU 873554A HU 355487 A HU355487 A HU 355487A HU T47848 A HUT47848 A HU T47848A
Authority
HU
Hungary
Prior art keywords
vulnerary
inflammation
promoting
producing pharmaceuticals
pharmaceuticals
Prior art date
Application number
HU873554A
Other languages
Hungarian (hu)
Other versions
HU201683B (en
Inventor
Janos Balint
Tamas Farago
Sandor Jancso
Janos Erdei
Istvan Kovacs
Jozsefne Emri
Gezane Horvath
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Priority to HU873554A priority Critical patent/HU201683B/en
Priority to BG85119A priority patent/BG49522A1/en
Priority to JP63192899A priority patent/JPH01117828A/en
Priority to ES8802427A priority patent/ES2007544A6/en
Priority to IT8821634A priority patent/IT1226586B/en
Priority to DE3826419A priority patent/DE3826419A1/en
Priority to FI883638A priority patent/FI883638A7/en
Priority to DD88318589A priority patent/DD272414A5/en
Priority to NL8801930A priority patent/NL8801930A/en
Priority to SE8802805A priority patent/SE8802805L/en
Priority to FR8810477A priority patent/FR2619011A1/en
Priority to AU20387/88A priority patent/AU612387B2/en
Priority to CS543688A priority patent/CS274600B2/en
Priority to BE8800899A priority patent/BE1001932A4/en
Priority to CH2943/88A priority patent/CH675833A5/de
Priority to GB8818575A priority patent/GB2207865B/en
Publication of HUT47848A publication Critical patent/HUT47848A/en
Publication of HU201683B publication Critical patent/HU201683B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/436—Inhibitors, antagonists of receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU873554A 1987-08-04 1987-08-04 Process for producing pharmaceutical compositions for promoting healing of wounds HU201683B (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
HU873554A HU201683B (en) 1987-08-04 1987-08-04 Process for producing pharmaceutical compositions for promoting healing of wounds
BG85119A BG49522A1 (en) 1987-08-04 1988-08-02 Pharmaceutist composition accelarating the healing of mounds
JP63192899A JPH01117828A (en) 1987-08-04 1988-08-03 Pharmaceutical composition that promotes wound healing and method for preparing the same
ES8802427A ES2007544A6 (en) 1987-08-04 1988-08-03 {RPCEDOMIENTO TO PREPARE PHARMACEUTICAL PREPARATIONS FOR STIMULATING WOUND HEALING.
IT8821634A IT1226586B (en) 1987-08-04 1988-08-03 PHARMACEUTICAL COMPOSITIONS THAT ENHANCE THE WOUND CICATRIZATION AND PROCEDURE TO PREPARE THEM
DE3826419A DE3826419A1 (en) 1987-08-04 1988-08-03 Wound healing promoting medicinal product and process for its manufacture
FI883638A FI883638A7 (en) 1987-08-04 1988-08-03 Method for preparing pharmaceutical preparations that promote wound healing.
DD88318589A DD272414A5 (en) 1987-08-04 1988-08-03 METHOD FOR PRODUCING A MEDICAMENT PREPARED FOR WOUND HEALING
NL8801930A NL8801930A (en) 1987-08-04 1988-08-03 PHARMACEUTICAL PREPARATIONS PROMOTING WOUND HEALING AND METHOD FOR THE PRODUCTION THEREOF
SE8802805A SE8802805L (en) 1987-08-04 1988-08-03 PHARMACEUTICAL COMPOSITION TO EASY TO CLEAR CARE AND PROCEDURE FOR THE PREPARATION OF THE SAME
FR8810477A FR2619011A1 (en) 1987-08-04 1988-08-03 PHARMACEUTICAL COMPOSITIONS FACILITATING HEALING OF INJURIES AND METHODS FOR PREPARING THE SAME
AU20387/88A AU612387B2 (en) 1987-08-04 1988-08-03 Pharmaceutical compositions promoting the wound healing and process for preparing same
CS543688A CS274600B2 (en) 1987-08-04 1988-08-03 Method of pharmaceutical preparation that promotes wound healing
BE8800899A BE1001932A4 (en) 1987-08-04 1988-08-03 Pharmaceutical composition to facilitate wound healing and methods for its preparation.
CH2943/88A CH675833A5 (en) 1987-08-04 1988-08-03
GB8818575A GB2207865B (en) 1987-08-04 1988-08-04 Pharmaceutical for wound healing comprising h-1 and/or h-2 blocker on a carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873554A HU201683B (en) 1987-08-04 1987-08-04 Process for producing pharmaceutical compositions for promoting healing of wounds

Publications (2)

Publication Number Publication Date
HUT47848A true HUT47848A (en) 1989-04-28
HU201683B HU201683B (en) 1990-12-28

Family

ID=10964527

Family Applications (1)

Application Number Title Priority Date Filing Date
HU873554A HU201683B (en) 1987-08-04 1987-08-04 Process for producing pharmaceutical compositions for promoting healing of wounds

Country Status (16)

Country Link
JP (1) JPH01117828A (en)
AU (1) AU612387B2 (en)
BE (1) BE1001932A4 (en)
BG (1) BG49522A1 (en)
CH (1) CH675833A5 (en)
CS (1) CS274600B2 (en)
DD (1) DD272414A5 (en)
DE (1) DE3826419A1 (en)
ES (1) ES2007544A6 (en)
FI (1) FI883638A7 (en)
FR (1) FR2619011A1 (en)
GB (1) GB2207865B (en)
HU (1) HU201683B (en)
IT (1) IT1226586B (en)
NL (1) NL8801930A (en)
SE (1) SE8802805L (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2636532B1 (en) * 1988-09-20 1993-11-19 Glaxo Group Ltd PHARMACEUTICAL COMPOSITIONS
IT1241521B (en) * 1990-07-31 1994-01-17 Polifarma Spa THEPERAUTIC USE OF RANITIDINE IN THE TREATMENT OF INTERESTING WOUNDS SKIN AND THE UNDERLYING FABRICS
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
DE4220736A1 (en) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Inclusion complexes of polymerized cyclodextrins with pharmaceutically active substances
GB9424562D0 (en) 1994-12-06 1995-01-25 Giltech Ltd Product
DE9420259U1 (en) * 1994-12-17 1995-02-09 Röhm GmbH, 64293 Darmstadt Debittered ranitidine preparation
PE100298A1 (en) * 1996-08-16 1999-01-11 Schering Corp TREATMENT OF ALLERGIC RESPONSES OF THE SUPERIOR RESPIRATORY TRACT
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
JP2001139477A (en) * 1999-11-17 2001-05-22 Coherent Technology:Kk Tissue cell growth promoting solution at the wound site
CA2471994A1 (en) 2001-12-31 2003-07-17 Ares Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
DE10355085A1 (en) * 2003-11-24 2005-06-23 Schure, Frank, Dr. wound dressing
CN103816560B (en) * 2014-03-03 2015-06-24 广西南宁博恩康生物科技有限公司 Colloidal fluid used for wound restoration and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE452109B (en) * 1973-01-29 1987-11-16 Pharmacia Ab SCIENTIFIC CLEANER EXTENDED SARYTOR
US4747845A (en) * 1983-10-17 1988-05-31 Enquay Pharmaceutical Associates Synthetic resin matrix system for the extended delivery of drugs
US4668228A (en) * 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
IE58373B1 (en) * 1986-06-18 1993-09-08 Bloomfield Frederick Jacob 5-Lipoxygenase pathway inhibitors

Also Published As

Publication number Publication date
FI883638A0 (en) 1988-08-03
FR2619011A1 (en) 1989-02-10
NL8801930A (en) 1989-03-01
GB2207865B (en) 1991-10-09
HU201683B (en) 1990-12-28
IT8821634A0 (en) 1988-08-03
CH675833A5 (en) 1990-11-15
AU612387B2 (en) 1991-07-11
SE8802805D0 (en) 1988-08-03
CS274600B2 (en) 1991-08-13
DE3826419A1 (en) 1989-02-16
SE8802805L (en) 1989-02-05
ES2007544A6 (en) 1989-06-16
GB8818575D0 (en) 1988-09-07
DD272414A5 (en) 1989-10-11
CS543688A2 (en) 1990-10-12
FI883638L (en) 1989-02-05
BG49522A1 (en) 1991-12-16
BE1001932A4 (en) 1990-04-17
IT1226586B (en) 1991-01-24
FI883638A7 (en) 1989-02-05
GB2207865A (en) 1989-02-15
JPH01117828A (en) 1989-05-10
AU2038788A (en) 1989-02-09

Similar Documents

Publication Publication Date Title
HU902447D0 (en) Process for producing amino-triazinones
HU208147B (en) Process for producing etoposide-aminophosphate derivatives
HUT47138A (en) Process for producing hyaluronic acid derivatives
HUT47644A (en) Process for producing avermeklin b derivatives
HU46335A (en) Process for producing 4-demethoxy-4-amino-anthracycline derivatives
HUT46672A (en) Process for producing 9-amino-tetrahydroacridine derivatives
HUT48245A (en) Process for producing imidazo-pyridin derivatives
YU10988A (en) Process for avermectine producing
SG22892G (en) Process for producing ibuprofen
HUT47848A (en) Process for producing pharmaceuticals promoting vulnerary inflammation
HUT47846A (en) Process for producing antimalarian pharmaceutical
HUT49322A (en) Process for producing amino-acid derivatives
GB2198437B (en) Process for producing ethanol
HUT47866A (en) Process for producing micoplasma-vaccine
HUT51333A (en) Process for producing new expression system
HUT48191A (en) Process for producing alkadiene derivatives and pharmaceuticals comprising same
DE3662884D1 (en) Process for producing 2-hydroxy-4-methyltetrahydropyran
EP0289942A3 (en) Process for producing fluorobenzaldehydes
HUT48896A (en) Process for producing acyl-derivatives
HUT48637A (en) Process for producing sialocyl-glycerolipides
IL86475A0 (en) Process for producing phosphinyl-amino acid derivatives
HUT44172A (en) Process for producing tablets
HUT49568A (en) Process for producing urea derivatives
HUT49854A (en) Process for producing 5-amino-1-phenyl-4-nitropyrazole derivatives
DE3565530D1 (en) Process for producing optically active phenylalanine

Legal Events

Date Code Title Description
HPC4 Succession in title of patentee

Owner name: BIOGAL GYOGYSZERGYAR RT,HU

HMM4 Cancellation of final prot. due to non-payment of fee